The role of cytokines, adhesion molecules, and chemokines in interleukin-2-induced lymphocytic infiltration in C57BL/6 mice

Journal of Clinical Investigation

Volumn 97, Issue 8, 1996, Pages 1952-1959

  Anderson, James A ^a   Lentsch, Alex B ^a   Hadjiminas, Dimitri J ^a,c   Miller, Frederick N ^a   Martin, Alvin W ^b   Nakagawa, Koji ^a   Edwards, Michael J ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion molecules; Chemokine; Cytokine; Interleukin 2; Lymphocytes

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL TISSUE; ARTICLE; CANCER; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; FEMALE; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BASE SEQUENCE; CELL ADHESION MOLECULES; CHEMOKINES; CYTOKINES; DNA PRIMERS; FEMALE; GENE EXPRESSION; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2; KIDNEY; LIVER; LUNG; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYOCARDIUM; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; RANTES; RECEPTORS, LYMPHOCYTE HOMING; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0030005718     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118627     Document Type: Article

References (38)

1. Rosenberg, S.A., M.T. Lotze, J.C. Yang, P.M. Aerbersold, W.M. Linehan, C.A. Seipp, and D.E. White. 1989. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann. Surg. 210:474-485.
2. Siegel, J.P., and R.K. Puri. 1991. Interleukm-2 toxicity. J. Clin. Oncol. 9: 694-704.
3. Edwards, M.J., B.T. Heniford, E.A. Klar, K.W. Doak, and F.N. Miller. 1992. Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL/6 mice but preserves antitumor efficacy. J. Clin. Invest 90:637-641.
4. Young. W.W., S. Hakomori, J. Durdik, and C.S. Henney. 1980. Identification of 9 ganglio-n-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells. J Immunol. 124:199-201.
5. Anderson, T.D , T.J. Hayes, M.K Gately, J.M. Bontempo. L.L. Stem, and G.A. Truitt. 1988. Toxicity of human recombinant interleukin-2 in the mouse is mediated by interleukin-activated lymphocytes: separation of efficacy and toxicity by selective lymphocyte subset depletion. Lab. Invest. 59:598-612.
6. Fraker, D.L., H.N. Langstein, and J.A. Norton. 1989. Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity. J Exp Med 170:1015-1020.
7. Shimizu, Y., W. Newman, T.V. Gopal, K.J. Horgan. N. Graber, L.D. Beall, G.A. van Seveter, and S. Shaw. 1991. Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1. and ELAM-1 and changes in pathway hierarchy under different activation conditions. J. Cell Biol. 113:1203-1212.
8. Pankonin, G., B. Reipert. and A. Ager. 1992. Interactions between interleukin-2-activated lymphocytes and vascular endothelium: binding to and migration across specialized and non-specialized endothelia. Immunology. 77 51-60.
9. Schall, T.J., K. Bacon, K.J. Toy, and D.V. Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature (Lond.). 347:669-671.
10. Schall, T.J., K. Bacon, R.D. Camp, J.W. Kaspari. and D.V Goeddel. 1993. Human macrophage inflammatory protein alpha (MIP-1α) and MIP-1α/β chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177:1821-1826.
11. Maghazachi, A.A., A. Al-Aoukaty, and T.J. Schall. 1994. C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. J. Immunol. 153:4969-4977.
12. Bianchi, G., M. Sironi, E. Ghibaudi, C. Selvaggini, M. Elices. P. Allavena, and A. Mantovani 1993. Migration of natural killer cells across endothelial cell monolayers. J. Immunol. 151:5135-5144.
13. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem. 162.156-159.
14. Chou, Q., M. Russell, D.E. Birch, J. Raymond, and W. Bloch. 1992 Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res. 20.1717-1723.
15. Kumagai, K , K. Itoh, R. Suzuki, S. Hinumo, and F. Saitoh. 1982 Studies of murine large granular lymphocytes: identification as effector cells in natural killer and T cytotoxicity J Immunol. 129:388-394.
16. Chisholm, P.L., C.A. Williams, and R.R. Lobb. 1993. Monoclonal antibodies to the integrin a-4 subunit inhibit the murine contact hypersensitivity response. Eur. J. Immunol. 23:682-688.
17. Scheynius. A., R.L. Camp, and E. Pure. 1993. Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1. J Immunol 150: 655-663
18. Issekutz, T.B. 1993. Dual inhibition of VLA-4 and LFA-1 maximally inhibits cutaneous delayed-type hypersensitivity-induced inflammation. Am. J. Pathol. 143:1286-1293.
19. Nedwin, G., L. Svedersky, T. Bringman, M. Palladino, and D. Goeddel. 1985. Effect of interleukin-2, interferon-γ, and mitogens on the production of tumor necrosis factor α and β. J. Immunol. 135:2492-2497.
20. Mier, J.W., G. Vachino, J.W.M. Van Der Meer, R.P. Numerof. S Adams, J.G. Cannon. H.A. Bernheim. M.B. Atkins, D.R. Parkinson, and C.A Dinarello. 1988. Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. J. Clin. Immunol. 8:426-436.
21. Dubinett, S.M., M. Huang, A. Lichtenstein, W.H. McBride, J. Wang, G Markovitz, D. Kelley, W.W. Grody, L.E. Mintz, and S. Dhanani 1994. Tumor necrosis factor-α plays a central role in interleukin-2-induced pulmonary vascular leak and lymphocytic accumulation. Cell. Immunol 157:170-180.
22. Dustin, M.L., R. Rothlein, A.K. Bhan, C.A. Dinnarello, and T.A. Springer. 1986. Induction by IL-1β and interferon-γ: tissue distribution. biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 137:245-254.
23. Cavender, D.E., D.O. Haskard, B. Joseph, and M. Ziff. 1986. Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers J. Immunol. 136:203-207.
24. Bacon, K.B., A. Gearing, and R. Camp. 1990. Induction of in vitro human lymphocyte migration by interleukin-3, interleukin-4, and interleukin-6. Cytokine. 2:966-974.
25. Issekutz, T.B. 1990. Effects of six different cytokines on lymphocyte adherence to microvascular endothelium and in vivo lymphocyte migration in the rat. J. Immunol. 144:2140-2146.
26. Colditz, I.G , and D.L. Watson. 1992. The effect of cytokines and chemotactic agonists on the migration of T lymphocytes into skin. Immunology 76:272-278.
27. Sljelid, R., and T. Eskeland. 1993. The biology of macrophages. I. General principles and properties. Eur. J. Haematol 51:267-275.
28. + T cell infiltration. J. Immunol. 149.2954-2960.
29. Mulligan, M.S., A.A. Vaporciyan, M. Miyasaka, T. Tamatani, and P.A. Ward. 1993. Tumor necrosis factor regulates in vivo intrapulmonary expression of ICAM-1. Am. J. Pathol 142:1739-1749.
30. Silber. A., W. Newman, V.G. Sasseville, D. Pauley, D. Beall, D.G. Walsh. and D.J. Ringler. 1994. Recruitment of lymphocytes during cutaneous delayed hypersensitivity in nonhuman primates is dependent on E-selectin and vascular cell adhesion molecule 1. J. Clin Invest 93:554-1563.
31. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76.301-314.
32. Miller, M.D., and M.S. Krangel. 1992. Biology and biochemistry of the chemokines: a family of chemotactic antiinflammatory cytokines. Crit. Rev. Immunol 12:17-46.
33. + T cells in response to MIP-1α and MIP-1β. Science (Wash DC) 26:355-358.
34. Miller, M.D., S. Hata, R. de Waal Malefyt, and M.S. Krangel. 1989. A novel polypeptide secreted by activated human T lymphocytes. J. Immunol. 143:2907-2916.
35. Zhou, Z., Y.J. Kim, K. Pollok, J. Hurtado, J.K. Lee, H.E. Broxmayer, and B.S. Kwon. 1993. Macrophage inflammatory protein-1 rapidly modulates its receptors and inhibits the anti-CD3 mAb-mediated proliferation of T lymphocytes. J. Immunol. 151:4333-4341.
36. Maltman, J., I.B. Pragnell, and G.J. Graham. 1993. Transforming growth factor β: is it a downregulator of stem cell inhibition by macrophage inflammatory protein 1β? J. Exp. Med. 178:925-932.
37. Rathanswami, P., M. Hachicha, and M. Sadich. 1993. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. J. Biol. Chem. 268:5834-5839.
38. Heeger, P., G. Wolf, and C. Meyers. 1992. Isolation and characterization of cDNA from renal tubular epithelium encoding murine RANTES. Kidney Int. 12:220-225